Ehave Provides Update on Digital Portal Patient Intake

TORONTO, Nov. 28, 2017 /PRNewswire/ -- Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today provided an update on the launch of its digital patient intake system. As of this announcement, Ehave has registered over 24,000 patients into its flagship informatics platform and is maintaining over 700,000 patient resources, including medical documents, medication requests, medication dispenses and psychological assessments.

These users have all been integrated into the Ehave Platform, whose recent upgrade leverages the functionality found within the Ehave Platform Core and simplifies the hosting of third-party digital tools and applications for mental health. Some of these users are also using the offerings of Ehave Connect, a digital "App Store" designed to enhance access to a broad array of content offered by Ehave and its growing roster of mental healthcare partners.

"The pace of patient registrations has been moving ahead of our expectations, and is indicative of growth and uptake in the medical community," said Prateek Dwivedi, CEO of Ehave. "As we move towards becoming a revenue-generating company, every new patient is an opportunity to demonstrate our ability to provide trusted and novel tools to enhance the lives of their patients."

About Ehave, Inc.
Ehave is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis and treatment. With Ehave Connect, Ehave's mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems ("MHS"), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder ("ADHD"), through its collaboration with the Hospital for Sick Children ("SickKids"). Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with MedReleaf. For more information, visit https://www.ehave.com/.

Forward-Looking Statement Disclaimer
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company's research, manufacturing and other development efforts; (ii) the Company's ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company's products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company's industry and introduction of competing products; (vi) the Company's ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.'s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov.

Contacts
Tiberend Strategic Advisors, Inc. 
Joshua Drumm, Ph.D. (Investors)
(212) 375-2664
[email protected]

Janine McCargo (Media)
646-604-5150
[email protected]

SOURCE Ehave, Inc.

Related Links

http://www.ehave.com